182 related articles for article (PubMed ID: 26579964)
1. Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model.
Marcus LP; Marshall D; Hirshman BR; McCutcheon BA; Gonda DD; Koiso T; Hattangadi-Gluth JA; Carter BS; Yamamoto M; Chen CC
Neurosurgery; 2016 Aug; 79(2):246-52. PubMed ID: 26579964
[TBL] [Abstract][Full Text] [Related]
2. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Importance of Cumulative Intracranial Tumor Volume in Patients with Gastrointestinal Brain Metastasis Treated with Stereotactic Radiosurgery.
Joshi RS; Hirshman BR; Ali MA; Alattar A; Carroll K; Nagano O; Aiyama H; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2019 Jan; 121():e747-e754. PubMed ID: 30308343
[TBL] [Abstract][Full Text] [Related]
4. Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases.
Hirshman BR; Wilson BR; Ali MA; Schupper AJ; Proudfoot JA; Goetsch SJ; Carter BS; Sinclair G; Bartek J; Chiang V; Fogarty G; Hong A; Chen CC
Neurosurgery; 2018 Aug; 83(2):237-244. PubMed ID: 28973506
[TBL] [Abstract][Full Text] [Related]
5. Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume for Stereotactic Radiosurgery-Treated Brain Metastasis Patients.
Hirshman BR; Wilson B; Ali MA; Proudfoot JA; Koiso T; Nagano O; Carter BS; Serizawa T; Yamamoto M; Chen CC
Neurosurgery; 2018 Apr; 82(4):473-480. PubMed ID: 28658940
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration.
Gonda DD; Kim TE; Goetsch SJ; Kawabe T; Watanabe S; Alksne JF; Hattangadi JA; Nitta M; Ott K; Hodgens DW; Carter BS; Yamamoto M; Chen CC
Eur J Cancer; 2014 Apr; 50(6):1148-58. PubMed ID: 24529832
[TBL] [Abstract][Full Text] [Related]
7. Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery.
Serizawa T; Higuchi Y; Nagano O; Matsuda S; Aoyagi K; Ono J; Saeki N; Iwadate Y; Hirai T; Takemoto S; Shibamoto Y
J Neurosurg; 2017 Nov; 127(5):1000-1006. PubMed ID: 27911235
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
9. Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery.
Donofrio CA; Cavalli A; Gemma M; Riccio L; Donofrio A; Panni P; Ferrari da Passano C; Del Vecchio A; Bolognesi A; Soffietti R; Mortini P
Clin Exp Metastasis; 2020 Aug; 37(4):499-508. PubMed ID: 32430649
[TBL] [Abstract][Full Text] [Related]
10. An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation status.
Ahluwalia M; Ali MA; Joshi RS; Park ES; Taha B; McCutcheon I; Chiang V; Hong A; Sinclair G; Bartek J; Chen CC
Neurooncol Adv; 2021; 3(1):vdaa152. PubMed ID: 33506199
[TBL] [Abstract][Full Text] [Related]
11. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.
Chiou SM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1156-62. PubMed ID: 20970031
[TBL] [Abstract][Full Text] [Related]
12. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
[TBL] [Abstract][Full Text] [Related]
13. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
[TBL] [Abstract][Full Text] [Related]
14. Cumulative Intracranial Tumor Volume as a Prognostic Factor in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery.
Hirshman BR; Compton J; Carroll KT; Ali MA; Wang SG; Chen CC
Acta Neurochir Suppl; 2021; 128():57-69. PubMed ID: 34191062
[TBL] [Abstract][Full Text] [Related]
15. Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery.
Stenman M; Benmakhlouf H; Wersäll P; Johnstone P; Hatiboglu MA; Mayer-da-Silva J; Harmenberg U; Lindskog M; Sinclair G
Acta Neurochir (Wien); 2021 Feb; 163(2):333-342. PubMed ID: 32902689
[TBL] [Abstract][Full Text] [Related]
16. Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries.
Marshall DC; Marcus LP; Kim TE; McCutcheon BA; Goetsch SJ; Koiso T; Alksne JF; Ott K; Carter BS; Hattangadi-Gluth JA; Yamamoto M; Chen CC
J Neurooncol; 2016 May; 128(1):119-128. PubMed ID: 26948673
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of upfront stereotactic radiosurgery for brain metastases with high cumulative intracranial tumor volume (> 7 ml): analysis of 233 consecutive patients.
Yomo S; Oda K; Oguchi K
Acta Neurochir (Wien); 2021 Apr; 163(4):991-1001. PubMed ID: 33398539
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
19. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
20. The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L
Radiat Oncol; 2016 Jul; 11():92. PubMed ID: 27411944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
